|
|
|
|
Your AusPharm member profile |
|
|
RGH E-Bulletin: Treatment-emergent affective switch
"Antidepressants are commonly used as adjuncts to mood-stabilising agents such as lithium or sodium valproate for patients with bipolar affective disorder. It has been reported that treatment with antidepressants may be associated with the induction of episodes of mania or hypomania in 15-40% of bipolar patients. The phenomenon of abnormal mood elevation during antidepressant treatment, or ‘treatment-emergent affective switch’ was first described in association with tricyclic antidepressants, and has now been reported for all major antidepressant classes."
Click here to read this E-Bulletin in full. The E-Bulletins are archived on the AusPharmList website here. Post a comment to AusPharmList.

Guild President warns employee pharmacists on wages In an opinion piece published in Pharmacy News on Friday (here), Guild President Kos Sclavos warns employee pharmacists that there is pressure on pharmacist wages in Australia and overseas.
Citing the global financial crisis and government policy as precipitating factors Mr Sclavos points out that pharmacists' wages have recently declined in many parts of the world.
He points out that, in Australia, "comments by some pharmacists will only cause damage to their own remuneration in the long term" adding that "the critics of community pharmacy from within our profession, who incorrectly believe community pharmacy owners are faring well and are calling for cuts in the Agreement, should keep in mind the jobs of their pharmacist colleagues." Post a comment to AusPharmList.

Nitschke to promote illegal pill ABC news
Darwin-based euthanasia campaigner Dr Philip Nitschke says he does not expect to be arrested for promoting a new illegal pill here and overseas. All today's 'In the news' links >

Use it or lose your retirement dreams ABC Health and Wellbeing
Staying active into your 70s, 80s and even 90s, is not only possible but vital to optimising quality of life, a growing body of evidence shows. All today's 'Last Word' links >

|
|
Tips for finding reliable health information sources on the web To help consumers find the best information sources on the internet, the National Prescribing Service (NPS) has published a guide in the latest edition of MedicinesTalk.
“There are a number of things to consider when you are searching for health information on the internet; most importantly that the content is accurate,” NPS CEO, Dr Lynn Weekes said. More >


Job of the day PHARMACISTS for CHRISTMAS ISLAND WA Are you looking for a complete change in scenery and the experience of a lifetime all rolled into one? We have an exciting opportunity available for 2 Full-Time Pharmacists to join the Health Focus Pharmacy team on Christmas Island. Christmas Island is a tiny dot in the Indian Ocean, located 2600km northwest of Perth, Western Australia. Even though it is an Australian Territory, its closest neighbour is Java, 360km away. Christmas Island is one of nature's most impressive feats, an island full of natural wonders: Yet it also displays a curious amalgam of cultures, history and industry, emerging as a place where all these elements create a truly unusual travel and work experience. More >

Get your PMP, DAA data in now The first data submission period for the Dose Administration Aids (DAA) and Patient Medication Profile (PMP) Programs opened on November 1 and will run through until 30 November 30.
Pharmacies who submit their data (here) in November are eligible for the payments of $1,000 for DAA and $750 for PMP.
If you haven’t yet registered for the programs, it's not too late. You can still register to participate here. Post a comment to AusPharmList.

Being boss takes its toll on health ABC Science
Being the boss might mean more money and challenging work but it can also take a toll on physical and mental well-being, according to a Canadian study. All today's 'Last Word' links >

|
|
AusPharmList Post of the day
Budget changes to start 1 Dec 09 Geoff Timbs The last Budget included 2 measures to start on 1/12/09. The first is a new therapeutic group for Atorvastatin and Rosuvastatin and presumably Crestor will be dropping their price or wearing a large premium from Dec 1st....don't do a bulk buy.
The second is to extend reference pricing to "all non-exempt items in a therapeutic group" to remove anomalies and save $61 million. Does anyone have any idea what this means...MA tells me to ask the Dept, the Dept says it is on their website but can't tell me where and the Guild is waiting for more info. This should be something we receive adequate notice to minimise windfall losses on stock on hand. All todays' AusPharmList posts >

AusPharm CE: RGH E-Bulletin Digest No. 17

The next in our 2009 series of continuing education activities is the RGH E-Bulletin Digest No. 17.
After completing this activity, pharmacists should be able to:
- Understand important drug interactions with urinary alkalinisers
- Describe important clinical aspects of refeeding syndrome
- Discuss the management of thiamine deficiency
- Describe the clinical pharmacology of bevacizumab
Click here to do this Continuing Education activity. Or, if you prefer, you might like to take a look at our other CE activities here .
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS. More >

Women Have Special Concerns with Prescription Medications Newswise
Most people have taken a prescription medication at one time or another, but according to a report from the Agency of Healthcare Research and Quality, not only do women take more medications during their lifetimes, women are more likely to suffer from adverse drug events than men. All today's 'Last Word' links >

|
|
|
Advertisers and Sponsors













|
|
|
|
| | Tips for finding reliable health information sources on the web |  | | | | | | | To help consumers find the best information sources on the internet, the National Prescribing Service (NPS) has published a guide in the latest edition of MedicinesTalk. “There are a number of things to consider when you are searching for health information on the internet; most importantly that the content is accurate,” NPS CEO, Dr Lynn Weekes said. “Check who has created the website and determine its purpose – has it been created to provide information, sell a product or tell a personal story? Be wary of sites that exist to sell a product or service. Some companies also use blogs and websites to gather patient stories and feedback for use in positioning their products,” Dr Weekes said. “When looking for information about specific medicines, particularly prescription medicines, it is best to use only Australian websites as product names vary from country to country.” “It’s also important to ensure the information is up to date. Good websites will say when its pages were last updated. Medical research is constantly evolving and information that was correct a year ago may no longer be considered relevant.”
 “Finally, if a website displays the HealthInsite (at left) or Health on the Net Foundation (HoN) logos (at right), it has been judged to be of good quality and suitable for consumers.” Some trust-worthy websites include:
www.betterhealthchannel.vic.gov.au www.mydr.com.au www.healthinsite.gov.au www.nps.org.au/consumers www.healthtranslations.vic.gov.au “Even if the information you find is from a reliable website, use it only as a guide. Try not to self-diagnose using information from the internet - if you are concerned about anything see your GP and tell them where you found the information,” Dr Weekes advised. To view the full article and others in the Spring edition of MedicinesTalk go to www.nps.org.au/consumers/publications/medicines_talk
Post a comment to AusPharmList.

| |
| | | AusPharm CE: RGH E-Bulletin Digest No. 17 |  | | | | | | | The next in our 2009 series of continuing education activities is the RGH E-Bulletin Digest No. 17.
This CE activity assesses your understanding of four recent RGH Pharmacy E-Bulletins (Volumes 35-6 to 35-9 --> September - October 2009).
After completing this activity, pharmacists should be able to:
- Understand important drug interactions with urinary alkalinisers
- Describe important clinical aspects of refeeding syndrome
- Discuss the management of thiamine deficiency
- Describe the clinical pharmacology of bevacizumab
Click here to do this Continuing Education activity. Or, if you prefer, you might like to take a look at our other CE activities here .
AusPharm gratefully acknowledges the financial support provided by the sponsors of our CE program, MIMS.
The competency standards addressed by this activity include (but may not be limited to) 3.1.2.; 3.1.3; 3.1.5; 3.2.2; 4.2.1; 4.2.2; 4.2.3, 7.3.2; 7.3.4.
Successfull completion of this activity is demonstrated by answering seven of the eight multiple choice questions correctly.
This activity has been accredited by the Pharmaceutical Society of Australia as a Group 2 activity for 0.75 point. Accreditation number: CX090048H.
Post a comment to AusPharmList.

| |
| | | AusPharm Job of the Day : PHARMACISTS for CHRISTMAS ISLAND WA |  | | | | | | | Are you looking for a complete change in scenery and the experience of a lifetime all rolled into one? We have an exciting opportunity available for 2 Full-Time Pharmacists to join the Health Focus Pharmacy team on Christmas Island. Christmas Island is a tiny dot in the Indian Ocean, located 2600km northwest of Perth, Western Australia. Even though it is an Australian Territory, its closest neighbour is Java, 360km away. Christmas Island is one of nature's most impressive feats, an island full of natural wonders: Yet it also displays a curious amalgam of cultures, history and industry, emerging as a place where all these elements create a truly unusual travel and work experience. Click anywhere below for more information about this job or to apply for this job. 
AusPharmJobs.net.au is the most comprehensive Pharmacy job network available in Australia today. Visit the AusPharmJobs.net.au website to search for a job or advertise a job here.

| |
| | | AusPharmList posts  |  | |
| | | | | | | - Budget changes to start 1 Dec 09....... Geoff Timbs 31/10/2009
- Indications for meds example....... Michael Post 30/10/2009
- NPS stroke prevention program....... David Haworth 30/10/2009
- Re: Demazin for young children S4....... amanda cronin 30/10/2009
- Re: Cough and cold preps for under sixes to go....... Peter Evans 30/10/2009
- Re: New packaging of Endone - congratulations and thank you to Sigma....... Peter Bayly 30/10/2009
- Re: Cough and cold preps for under sixes to go....... Greg Stark 30/10/2009
- Re: Cough and cold preps for under sixes to go....... amanda cronin 30/10/2009
- Re: New packaging of Endone - congratulations and thank you to Sigma....... Ritche Andit 30/10/2009
- Re: Catholic chemist wont sell the pill - Ethics and Standards ....... Peter Bayly 30/10/2009
- Re: PROJECT STOP AND RXS FOR SUDAFED....... Michael Jensen 30/10/2009
- Re: PROJECT STOP AND RXS FOR SUDAFED....... Francis Ip 30/10/2009
- Re: PROJECT STOP AND RXS FOR SUDAFED....... Peter Evans 30/10/2009
- Re: PROJECT STOP AND RXS FOR SUDAFED....... 30/10/2009
- Re: Cough and cold preps for under sixes to go....... Stuart Baker 30/10/2009
- Re: Cough and cold preps for under sixes to go....... Peter Evans 30/10/2009
| |
| | | 1. Budget changes to start 1 Dec 09 |  | | | | | | |
| | From: "Geoff Timbs" warnersbay@amcal.net.au The last Budget included 2 measures to start on 1/12/09. The first is a new therapeutic group for Atorvastatin and Rosuvastatin and presumably Crestor will be dropping their price or wearing a large premium from Dec 1st....don't do a bulk buy.
The second is to extend reference pricing to "all non-exempt items in a therapeutic group" to remove anomalies and save $61 million. Does anyone have any idea what this means...MA tells me to ask the Dept, the Dept says it is on their website but can't tell me where and the Guild is waiting for more info. This should be something we receive adequate notice to minimise windfall losses on stock on hand.
Geoff Timbs B.Pharm
|
| | |
|
| | | 2. Indications for meds example |  | | | | | | |
| | From: "Michael Post" piosto1@hotmail.com Patient presents hospital script to me thismorning:
Aspirin 150mg d Simvastatin 40mg 1 n Karvezide 300/25 1 m Metformin 1000mg 1 bd
Me: Why are you taking these meds??
Customer: They thought I might have had a stroke because my speech was slurred for 30 mins on Monday. I had an MRI and they say I'm OK now.
Me:Did they mention the anacronym TIA to you?
Customer: Yes- they said I had a TIA
Me; When are you seeing GP?
Customer: Seeing GP on Monday
Me: Any allergies and have you ever had a heart attack or angina?
Customer: No and no
Me: You need to see your GP righ away to get appropriate medicine to prevent stroke. When you see your GP please ask him/her for a health summary sheet print out. With your permission I would like to be involved in your health and because I am not privy to your medical diagnoses I cannot help fill any gaps that might be missing in your treatment PLUS I can keep an eye on your dispensing history to ensure you are taking the medicines you are supposed to be taking regularly.
Customer: Thankyou so much.
Another life saved.
Asasantin as opposed to aspirin should be prescribed in my customer's case hence he become another stroke victim within 1 week of TIA.
I ask all customers for health summaries from their GP if they want me to become a part of their team rather than a potential contributor to medication misadventure.
Low and behold in the last 2 health summaries I have picked up clinically SIGNIFICANT gaps in treatment.
Geez- we might just complement doctors at this rate- its just a shame its not standard.
Customer
|
| | |
|
| | | 3. NPS stroke prevention program |  | | | | | | |
| | From: "David Haworth" pugnutty@gmail.com I see Katie Butt from the NPS reads the list - I read the GP's News and Review links but no where did the NPS advise the GP's to avoid PPI's ( exception Somac) due to the Cytochrome interaction (with clopidigrel). Could Katie comment on this? I advised a GP of the interaction and she called me back saying that explained her patient with thrombolisms who was already on Clopidogrel and Nexium.
David Haworth
|
| | |
|
|
| | | |  | | | | | | |


| |
|
| | | | | | 4. Re: Demazin for young children S4 |  | | | | | | |
| | From: "amanda cronin" healthglo@hotmail.com What worries me is that parents have cottoned on and now lie about the age of the child to get it. This leave us in no position to tell them the correct dose for the age so they guess. Potentially more dangerous. And I bet it happens all the time. I have done it myself while on holiday.
|
| | |
|
| | | 5. Re: Cough and cold preps for under sixes to go |  | | | | | | |
| | From: "Peter Evans" wynnum@amcal.net.au Andrew Topp wrote: "So where are all these reports of serious adverse events?"
and Ken Harvey wrote:
See: "Labelling and packaging of cough and cold medicines - proposed changes to requirements. Consultation". http://www.tga.gov.au/npmeds/consult/drlp-ccmedicines.htmEspecially see, "TGA internal panel report on a review of the safety and efficacy of cough and cold medicines in the treatment of children aged 2-12 years (pdf,153kb)"
----------
Andrew asked for the evidence, Ken directed us to TGA's report on the matter.
In summary the above report uses the TGA's own Adverse Drug Reaction data, which is a credible idea, better than overseas data about ingredients sold through non-pharmacy outlets and ingredients not even available in Australia.
It wades through some general statistics, then gets down to the only specific evidence of ADRs from cough & cold ingredients offered in the whole report:
2 deaths since 1981, as follows:
'the first occurred in a 1 year old infant administered oxymetazoline and morphine the second death occurred in a 2 year old child administered ipecacuanha (unclear whether ipecacuanha used for its expectorant or emetic properties) in combination with other medications'
That is it! Two deaths, vaguely/maybe linked to oxymetazoline & ipecacuanha in 28 years. These were the only specific cases discussed.
We are not told if the links to these specific ADRs were probable, possible or unclear.
So for all we know, the TGA is considering restricting the access of cough & cold medicine relief to any sick child under 12 because an infant died of a morphine ADR, whilst using coincidentally using oxymetazoline administered intranasally or any number of other possibilities unrelated to conventional use. Worse still the ipecacuanha link is so vague I can't believe it was included (and to my knowledge it is only present in Mixt. Ipecac et Tolu, which hardly relates to the extensive list of ingredients under review.
Peter Evans (Community Pharmacist)
|
| | |
|
| | | 6. Re: New packaging of Endone - congratulations and thank you to Sigma |  | | | | | | |
| | From: "Peter Bayly" peter.bayly@bigpond.com Bill Arnold wrote:
"
Please describe for me a calendar pack designed for products where there can be be frequent dosage changes.'
----------
How about 2 strips of 28. Easy for single dose, easy for double dose. Discard second half of half dose.
Not perfect, but much better for most patients most of the time especially those who don't mark it off on any other record.
Peter B, thankful for the responses :-)
|
| | |
|
| | | 7. Re: Cough and cold preps for under sixes to go |  | | | | | | |
| | From: "Greg Stark" janshepherd5@bigpond.com Francis Ip wrote:
"I have a (admittedly cynical) belief that paediatric symptomatic treatments are not for the benefit of the child but for the parents. Most children seems fairly happy to run around with a cough or runny nose that is not going to harm them and causes negligible loss in quality of life. It is the adults who are most affected by the child being sick and suffer a large loss in quality of life (the burden of being a 'bad parent'!). Sometimes I think medicating the adults will provide a better outcome!"
----------
Anybody remember seeing the release of "Obecalp" capsules a year or 2 ago? It was simply clever marketing of a placebo capsule.
Perhaps it's time for "Obecalp" to bring out a syrup, nasal drops, etc to fill in the obvious gap in our market ;)
|
| | |
|
| | | 8. Re: Cough and cold preps for under sixes to go |  | | | | | | |
| | From: "amanda cronin" healthglo@hotmail.com "So the review actually shows 40-67%"
----------
My problem with this type of testing is it is subjective. The person taking the placebo will feel better becuase there condition is improving so may put it down to the medicine. The same person could also take the medication and the symptoms will improve much more, but with out the other experience to compare it to will rate it the same. It is obvious to any parent who's kid stops crying, the nose stops running( for a few hrs at least)and peace is in the house that they do work. I know I'll be stocking up for my family before this is recheduled.
|
| | |
|
| | | 9. Re: New packaging of Endone - congratulations and thank you to Sigma |  | | | | | | |
| | From: "Ritche Andit" r.andit@bigpond.net.au Greg Stark wrote:
"By the way, whatever happened to the push to remove Marevan from the market as (if I remember the figures) only 5% of people use the Marevan brand?"
----------
Marevan is more popular in our area.
|
| | |
|
| | | 10. Re: Catholic chemist wont sell the pill - Ethics and Standards |  | | | | | | |
| | From: "Peter Bayly" peter.bayly@bigpond.com Greg Stark wrote:
"...to bring about someone's death? From my understanding, barbiturates have been the drug of choice."
----------
check out the toxicity of amitriptyline + alcohol
|
| | |
|
|
| | | |  | | | | | | | 

| |
|
| | | | | | 11. Re: PROJECT STOP AND RXS FOR SUDAFED |  | | | | | | |
| | From: "Michael Jensen" toadsquasher@hotmail.com michelle gerrie wrote:
"Are we meant to still get a photo ID if someone presents to the pcy with a Rx for Sudafed etc? Had a dodgy looking person come in with a legitimate Rx as he does not have any photo ID."
----------
No photo ID? How about a Credit/Debit card with the persons name on it. Would be able to establish their identity from that.
|
| | |
|
| | | 12. Re: PROJECT STOP AND RXS FOR SUDAFED |  | | | | | | |
| | From: "Francis Ip" francisi@tpg.com.au michelle gerrie wrote:
"Are we meant to still get a photo ID if someone presents to the pcy with a Rx for Sudafed etc? Had a dodgy looking person come in with a legitimate Rx as he does not have any photo ID."
----------
A script is a script. As long as the prescription looks legitimate and you have done your best to ensure it isn't forged then I would dispense it and counsel just like any other script. I believe Project STOP is designed for OTC use, and I haven't heard anyone use it for S4's yet.
In Victoria it is not required for patients to present ID to put in a prescription or to pick up a script (except maybe to verify that it is the correct script to hand out - this is a matter of patient safety, not about legality). I am unsure about laws in other states, though I don't think it would be a requirement because it would wreak havoc on agency issues (i.e. picking up for someone else).
The scenario here could be: this patient tried to get the product OTC but because he 'looked dodgy' and had no ID for Project STOP he was refused. A pharmacist told him the only way was to get a script. He then proceeded to do the right thing and is now back at the pharmacy. To refuse any further at this point I think would be silly - you may as well ban/not stock the product.
In my opinion, pharmacists aren't supposed to be policing medication use in this manner. I believe that the reason they are still S3 is that many people genuinely need the product, and not supplying it to these people would be a failure of care. I also believe that visual appearance isn't the best indicator of authenticity.
If they answer all my questions, and I ask the same set of questions regarding symptoms and other medication/conditions to everyone, and they can satisfy me that there is a need for PSE, I give it out after making a record and counselling. I try to treat everyone equally. I will, however, ask the questions faster if the patient smells funny or puts on too much perfume because I have to hold my breath and I can't hold it for that long. Going to the back to get the product will then allow me to breath again!
-Francis
p.s. can't wait for national legislation so I don't have to qualify all my statements with 'In Victoria'
|
| | |
|
| | | 13. Re: PROJECT STOP AND RXS FOR SUDAFED |  | | | | | | |
| | From: "Peter Evans" wynnum@amcal.net.au michelle gerrie wrote:
"Are we meant to still get a photo ID if someone presents to the pcy with a Rx for Sudafed etc? Had a dodgy looking person come in with a legitimate Rx as he does not have any photo ID."
----------
No ID = No Supply
|
| | |
|
| | | 14. Re: PROJECT STOP AND RXS FOR SUDAFED |  | | | | | | |
| | michelle gerrie wrote:
"Are we meant to still get a photo ID if someone presents to the pcy with a Rx for Sudafed etc? Had a dodgy looking person come in with a legitimate Rx as he does not have any photo ID."
----------
We have had a problem in our town recently with large numbers of people trawling the pharmacies for pse products. we've made it a blanket policy we will ONLY accept a drivers licence (not even 18+ card) for ID, and it MUST be presented for prescriptions as well. The (dodgy) people here have clued on, and some of the nice young drs have been accommodating with prescriptions (inclduing increased quantities AND repeats). Project stop has a little check-box where you can note if the person had a script.
I had one detective describe our town as the amphetamine capital of Australia. (increase in local violence the last couple of months....interesting??)
Having said that, when I called the police station this morning with rego number of a car involved in multiple purchases, I didn't get a great response.
Looking forward to everyone else's response.
**Moderator's note: seems like a good idea to de-identify this one so that the town / doctors / police can't be identified - MD**
|
| | |
|
| | | 15. Re: Cough and cold preps for under sixes to go |  | | | | | | |
| | From: "Stuart Baker" drugwise@southernphone.com.au Katie Butt wrote:
"It would be good for your comments about the article ‘Cough and Cold Remedies for Children’ to be addressed by Australian Prescriber. May I suggest that you put them into a letter to the editor?"
----------
Dear Katie,
Thank you for that suggestion. Before I go to the trouble of spending more time and effort on this subject I would like to see the authors' response to AusPharmList where the debate is being conducted. If they would care to respond to AusPharmList then I will consider writing to the Editor of Australian Prescriber after seeing their response.
Kind Regards,
Stuart Baker
|
| | |
|
|
| | | |  | | | | | | | -

| |
|
| | | | | | 16. Re: Cough and cold preps for under sixes to go |  | | | | | | |
| | From: "Peter Evans" wynnum@amcal.net.au Stuart Baker wrote:
"The results as reported in the Australian Prescriber (AP) article are misleading ..."
----------
Stuart,
You have obviously gone to a lot of trouble to review this article and it seems, as Frances Ip also points out, the statistics are vague enough to be interpreted in different ways. In any case, there doesn't seem to be conclusive evidence to support the statement 'Cough and cold medicines should be avoided in children under two years and should not be recommended in children any age, particularly those with...'(reasons a pharmacist would avoid recommending such products).
If you do submit a response perhaps you could also query the relevance of some of the contents of Table 1 supporting the article. For example has 'serotonin syndrome' ever been reported in an Australian child under 2, who has taken 'Antitussives, Pholcodine/Dextromethorpan' alone?
In Australia, especially Qld & WA, most of these medicines are behind the counter and supplied by trained staff under the supervision of the pharmacist. No other health care provider is more experienced in handling these products(don't get me started on correcting Demazin overdoses inadvertently prescribed by GPs).
Peter Evans
|
| | |
|
|
| | | In the news  |  | | | | | | |
| | Ascent shares soar on Pfizer deal Sydney Morning Herald 29/10/2009 Ascent Pharmahealth has entered into a distribution and services agreement with Pfizer Australia to promote and sell the full range of Pfizer’s established off-patent medicines to Australian pharmacies. The deal was struck via Ascent’s generics business, Genepharm Australia. More...
Post a comment to AusPharmList.
 |
| Advertisers and Sponsors


|
| |
| | | The last word  |  | | | | | | |
| | Sodium Oxybate Reduces Fibromyalgia Pain and Fatigue Medscape 29/10/2009 Sodium oxybate (Xyrem, Jazz Pharmaceuticals Inc.), a novel sleep medication approved by the US Food and Drug Administration (FDA) for the treatment of narcolepsy and cataplexy, offers safe and significant reduction of pain and fatigue in patients with fibromyalgia, according to a study presented here at the American Association of Pain Management 20th annual clinical meeting. More...
Post a comment to AusPharmList.
 |
| |
| | | About AusPharm(e)news |  | | | | | | | | | AusPharm(e)news is a daily ezine published by AusPharm.net.au P/L incorporating:
- posts to the AusPharmList discussion forum
- industry news
- links to pharmacy relevant pieces in the mainstream media
- AusPharm Practice pearls
- AusPharm feature articles
AusPharm(e)news is published each week day and is emailed to subscribers each morning, usually between 7AM and 8AM.
AusPharm.net.au P/L is a company owned by Tasmanian pharmacists Mark Dunn and Tony Wiss.
|

| |
| | | AusPharm supporters |  | | | | | | | 
| |
| | | Contact AusPharm |  | | | | | | | 
| |
| | | Frequently asked questions |  | | | | | | | | |
How to post to AusPharmList
Posting a new thread.
- Post by email --> Send your post by email to auspharmlist@auspharmlist.net.au
- Post online --> At the AusPharmList website click on the "Start new thread' Link and follow the prompts. Please note that your post won't immediately appear online as it needs to be reviewed by the moderator first.
- From AusPharm(e)news using the online method --> Click on the button
and follow the prompts. Please note that your post won't immediately appear online as it needs to be reviewed by the moderator first.
- From AusPharm(e)news by email --> Click on the button
and then compose and send your post.
Replying to an existing thread
- From AusPharm(e)news by email --> Click on the button
. We are aware that there is an error here for some people and while this button will work most of the time for most people, it will occasionally fail
- From AusPharm(e)news using the online option --> Click on the button
and follow the prompts. Please note that your post won't immediately appear online as it needs to be reviewed by the moderator first.
- From the AusPharmList website --> when viewing a post online at the AusPharmList website, there is a link with each post to "Reply to this post" --> Click on this link and follow the prompts. Please note that your post won't immediately appear online as it needs to be reviewed by the moderator first.
Issues with receiving and reading AusPharm(e)news
Most (but not all) people using the following email applications report that they can read AusPharm(e)news without difficulty.
- Outlook Express
- Outlook
- Eudora
- Hotmail
- Yahoo Mail
- Thunderbird
- Netscape Mail
There are however some issues that we know about for some people.
Some versions of Norton anti virus/spam software recognise the (e)news as spam and put it in the spam folder for some people. For some of these people it doesn't seem possible to tell Norton that the (e)news isn't spam and have it appear in your email inbox. There do not appear to be issues with spam filters other than other than this one. On some days, however, keywords displayed in the subject line of the day's (e)news may trigger all spam filters to see the (e)news as spam (eg V***ra)
Some people have reported that they were getting the text but not the images in the (e)news. This was resolved for most of these people by changing a setting in the email program options. For example, in Outlook Express: go to Tools --> Options --> Security and UNcheck the box that says "Block images and other external content in html email". Most email applications will have a similar option to turn on or off, as the case may be.
There seem to be a few issues that are unique to particular workplaces (and specific mail servers), with a couple of organisations reporting that members are not receiving the (e)news at all. One organisation is receiving it but their members' email application (Outlook) refuses to recognise the incoming (e)news as a web page, rendering it unreadable.
Different email clients seem to handle the enews in different ways. Some people receive it as a "inline" formatted email (ie it appears in the body of the email) while for others it appears as an attachment that must be clicked on to open. It may be possible to change this by changing the settings within the individual email application in question.
It is also clear that people are having issues that appear to be unique to them and we would be pleased to work with these people individually to resolve their problems. After reviewing the information above, and seeking assistance locally where available, please send a detailed description of your issue by email to mark@auspharm.net.au and we will see if we can help.
Each day AusPharm(e)news comes with a text only link to the online version. If all else fails, people having difficulty reading the (e)news should be able to read it without difficulty at the online location. There is a link to each day's online (e)news from the main AusPharm web page @ www.auspharm.net.au
|

| |
|
|
|  |